Susceptibility of environmental versus clinical strains of pathogenic Aspergillus
- 1 January 2007
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 29 (1) , 108-111
- https://doi.org/10.1016/j.ijantimicag.2006.09.019
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Epidemiology and outcome of infections due to Aspergillus terreus: 10‐year single centre experienceBritish Journal of Haematology, 2005
- Antifungal Susceptibility and Pathogenic Potential of Environmental Isolated Filamentous Fungi Compared with Colonizing Agents in Immunocompromised PatientsMycopathologia, 2005
- Antifungal Susceptibility of 596 Aspergillus fumigatus Strains Isolated from Outdoor Air, Hospital Air, and Clinical Samples: Analysis by Site of IsolationAntimicrobial Agents and Chemotherapy, 2005
- Azole and fungicide resistance in clinical and environmentalAspergillus fumigatusisolatesMedical Mycology, 2005
- Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factorsBlood, 2002
- In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium sppAntimicrobial Agents and Chemotherapy, 2002
- Susceptibility Testing of Aspergillus flavus : Inoculum Dependence with Itraconazole and Lack of Correlation between Susceptibility to Amphotericin B In Vitro and Outcome In VivoAntimicrobial Agents and Chemotherapy, 2001
- Antifungal drug susceptibility testing and resistance in AspergillusDrug Resistance Updates, 1999
- In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosisJournal of Antimicrobial Chemotherapy, 1998
- In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.Journal of Antimicrobial Chemotherapy, 1998